ArmCAM在卒中康复中的反应性、最小临床重要差异与预测效度
本研究基于多中心随机对照试验的二次分析,纳入62例卒中患者,评估远程上肢功能评定工具ArmCAM的反应性、最小临床重要差异(MCID)与预测效度。结果显示ArmCAM反应性高(SRM=0.92),基于锚定法的MCID为2.5-3.3,基线ArmCAM对REACH量表与SIS手功能域有中等预测效度,推荐用于远程康复。
要点
- ArmCAM在3周远程上肢训练后反应性高,SRM=0.92。
- 基于REACH、SIS手功能域和SIS恢复评分的MCID分别为3.3、2.5、2.7。
- 基线ArmCAM对REACH(ρ=0.61)和SIS手功能域(ρ=0.59)有中等预测效度。
核心结论
- ArmCAM可作为卒中后上肢运动功能的反应性和预测性远程评估工具,其MCID估计为评估临床获益提供依据。
研究设计与样本
- 多中心随机对照试验的二次分析,62例卒中患者(平均年龄62.7岁,32.3%女性,平均卒中后221.9天),接受3周远程上肢运动计划。
主要发现
- ArmCAM对干预后上肢运动功能变化反应性高(SRM=0.92)。
- 基于锚定法的MCID:REACH量表3.3,SIS手功能域2.5,SIS恢复评分2.7;基于分布法MCID为3.2。
- 基线ArmCAM对REACH量表(ρ=0.61)和SIS手功能域(ρ=0.59)有中等预测效度,对SIS恢复评分(ρ=0.44)预测效度一般。
关键数值与推荐
- 反应性:SRM=0.92。
- 锚定法MCID:REACH量表3.3,SIS手功能域2.5,SIS恢复评分2.7。
- 分布法MCID:3.2。
- 预测效度:REACH量表ρ=0.61,SIS手功能域ρ=0.59,SIS恢复评分ρ=0.44。
临床怎么用
- 在远程康复中可使用ArmCAM评估卒中后上肢运动功能,并以MCID≥2.5-3.3作为临床获益参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Arm Capacity and Movement Test (ArmCAM) is a remotely delivered measure for evaluating upper extremity motor function poststroke. This study examined the responsiveness, minimal clinically important difference (MCID), and predictive validity of the ArmCAM in individuals with stroke undergoing rehabilitation therapy. DESIGN: Secondary analysis of a multisite randomized controlled trial. SETTING: Participants' homes. PARTICIPANTS: Sixty-two individuals with stroke (mean age=62.7 years, 32.3% women, mean time poststroke=221.9 days). INTERVENTIONS: A 3-week virtually delivered upper extremity exercise program. MAIN OUTCOME MEASURES: The ArmCAM, the Rating of Everyday Arm-use in the Community and Home (REACH) Scale, and the Stroke Impact Scale (SIS) were administered remotely via videoconferencing. These assessments were conducted before and after the intervention. The standardized response mean (SRM) was calculated for responsiveness. Anchor- and distribution-based methods were used to estimate the MCID. Predictive validity was assessed using the Spearman correlation coefficient (ρ). RESULTS: ArmCAM demonstrated high responsiveness to changes in upper extremity motor function after the intervention (SRM=0.92). The anchor-based MCID estimates were 3.3, 2.5, and 2.7 for the REACH Scale, the SIS Hand Function Domain, and the SIS Recovery Score, respectively. The distribution-based MCID estimate was 3.2. Baseline ArmCAM scores showed moderate predictive validity for posttest scores on the REACH Scale (ρ=0.61) and in the SIS Hand Function Domain (ρ=0.59), and fair predictive validity for SIS Recovery Scores (ρ=0.44). CONCLUSIONS: The findings support the use of ArmCAM as a responsive and predictive remote assessment tool for evaluating upper extremity motor function poststroke. Its MCID estimates provide essential information for evaluating clinical benefits. ArmCAM is recommended for use in telerehabilitation contexts.
引用
- Yang CL, Chen CH, Simpson LA, et al. Responsiveness, Minimal Clinically Important Difference, and Predictive Validity of the ArmCAM in Stroke Rehabilitation: A Remotely Delivered Upper Extremity Function Assessment. Arch Phys Med Rehabil. 2026. PMID: 42177962. doi:10.1016/j.apmr.2026.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。